Group 1 - The first domestic nine-valent HPV vaccine was administered in Fuyang, Anhui Province, on November 26, 2025, benefiting women aged 9 to 45 and promoting primary prevention of cervical cancer [2] - A recent conference in Beijing gathered experts from various cancer fields to discuss advancements in diagnosis and treatment, emphasizing the importance of clinical research innovation in improving patient outcomes [3][4] Group 2 - Significant progress has been made in the treatment of gastrointestinal tumors in China, with innovative drugs driving updates in authoritative treatment guidelines and new clinical research strategies emerging [4] - The treatment of urological tumors is evolving towards a combination of surgery and medication, with advancements in minimally invasive techniques and drug therapies improving patient outcomes [5] Group 3 - The treatment landscape for nasopharyngeal carcinoma is being optimized, with immunotherapy becoming a first-line option for advanced cases, significantly improving survival rates [6] - CAR-T cell therapy and targeted drugs are providing long-term survival opportunities for patients with hematological tumors, although challenges remain in early diagnosis and treatment accessibility [6] Group 4 - The industry is moving towards a new era of precision, individualized, and multidisciplinary collaboration in cancer treatment, with a consensus on the need to enhance diagnostic and treatment systems [7] - The "People's Good Doctor · Camellia Plan" aims to promote the translation of research findings into clinical practice and improve healthcare services for the public [8]

Group 1 - The fifth "People's Good Doctor · Jinshan Camellia Plan" academic exchange focused on esophageal and gastric cancer, emphasizing the need for standardized and precise treatment in gastrointestinal tumors [1] - Esophageal cancer is a common malignant tumor globally, with significant advancements in clinical research, particularly in targeted and immunotherapy [1] - The plan aims to enhance the clinical skills of young and middle-aged doctors by integrating basic research with clinical practice, promoting a feedback loop between laboratory findings and clinical observations [1] Group 2 - Gastric cancer presents challenges due to its biological heterogeneity, which affects clinical research and personalized treatment [2] - Recommendations for gastric cancer treatment include active participation in multi-center clinical studies and improving communication skills among clinicians to optimize patient management [2] - Young and middle-aged doctors should solidify their foundational knowledge in oncology and engage in multidisciplinary teams to gain experience in individualized treatment approaches [2] Group 3 - The "People's Good Doctor · Jinshan Camellia Plan" serves as a vital platform for young doctors to share research findings and clinical experiences, enhancing their professional capabilities [3] - The initiative, launched in 2020, aims to promote the clinical translation of research outcomes and improve cancer prevention and control efforts [3] - The plan highlights the contributions of young experts in various cancer treatment fields, including lung, liver, gastric, esophageal, breast, gynecological, urological, lymphoma, and nasopharyngeal cancers [3]